Osteoprotegerin : A Promising Biomarker in the Metabolic Syndrome-New Perspectives

@inproceedings{Villacampa2016OsteoprotegerinA,
  title={Osteoprotegerin : A Promising Biomarker in the Metabolic Syndrome-New Perspectives},
  author={Carmen Perez de Ciriza Villacampa},
  year={2016}
}
  • Carmen Perez de Ciriza Villacampa
  • Published 2016
The metabolic syndrome (MS) is a cluster of cardio-metabolic alterations that has been known to increase the cardiovascular risk in these patients. The pathophysiological mechanisms underlying this observation remain unclear. In this context, osteoprotegerin (OPG) has emerged as a possible mechanism. The implication of OPG in cardiovascular disease and cardiovascular risk, the expression of this cytokine in different cells involved in the atheroma and the increased circulating concentration… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 32 references

321-329

A VanCampenhout, Golledge J Osteoprotegerin, vascular calcification, atherosclerosis. Atherosclerosis 204
Citation: Villacampa CPC • 2016
View 3 Excerpts

821-835

HP Sennels, S Jacobsen, +7 authors 67 high-sensitivityC-reactiveprotein.ScandJClinLabInv
Citation: Villacampa CPC • 2016
View 1 Excerpt

Osteoprotegerin in Cardiometabolic Disorders

International journal of endocrinology • 2015
View 2 Excerpts

Influence of pre-analytical and analytical factors on osteoprotegerin measurements

C Perez de Ciriza, A Lawrie, N Varo
Clin Biochem • 2014
View 3 Excerpts

Similar Papers

Loading similar papers…